Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect?

Neuropharmacology

Volumn 72, Issue , 2013, Pages 179-186

  Moritz, Steffen ^a   Andreou, Christina ^a   Klingberg, Stefan ^b   Thoering, Teresa ^a   Peters, Maarten J V ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antipsychotics; Cognition; Compliance; Emotion; Psychosis

Indexed keywords

DOPAMINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AWARENESS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG WITHDRAWAL; EFFECT OF ANTIPSYCHOTIC MEDICATION ON EMOTION AND COGNITION; EMOTION; EMOTIONAL DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; OBSESSIVE COMPULSIVE DISORDER; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; STEREOTYPY;

EID: 84884839760     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.039     Document Type: Article

References (79)

1. Andreou, C., Moritz, S., Veith, K., Veckenstedt, R., Naber, D. Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study. Schizophrenia Bulletin, in press.
2. Awad, A.G., Hogan, T.P., Voruganti, L.N.P., Heslegrave, R.J., 1995. Patients subjective experiences on antipsychotic medications: implications for outcome and quality of life. International Clinical Psychopharmacology 10, 123-132. (Pubitemid 26054886)
3. Bell, V., Halligan, P.W., Ellis, H.D., 2006. Explaining delusions: a cognitive perspective. Trends in Cognitive Sciences 10, 219-226. (Pubitemid 44275314)
4. Belmaker, R.H., Wald, D., 1977. Haloperidol in normals. British Journal of Psychiatry 131, 222-223.
5. Birchwood, M., Smith, J., Drury, V., Healy, J., Macmillan, F., Slade, M., 1994. A selfreport insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica 89, 62-67. (Pubitemid 24028268)
6. Brett, C.M.C., Johns, L.C., Peters, E.P., McGuire, P.K., 2009. The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-help-seeking groups of people experiencing psychoticlike anomalies. Psychological Medicine 39, 939-950.
7. Byerly, M.J., Nakonezny, P.A., Lescouflair, E., 2007. Antipsychotic medication adherence in schizophrenia. Psychiatric Clinics of North America 30, 437-452. (Pubitemid 47284561)
8. Camprubi, N., Almela, A., Garre-Olmo, J., 2008. Psychometric properties of the Spanish validation of the insight scale. Actas Espanolas De Psiquiatria 36, 323-330.
9. Chinman, M., Young, A.S., Schell, T., Hassell, J., Mintz, J., 2004. Computer-assisted self-assessment in persons with severe mental illness. Journal of Clinical Psychiatry 65, 1343-1351.
10. Combs, D.R., Adams, S.D., Penn, D.L., Roberts, D., Tiegreen, J., Stem, P., 2007. Social cognition and interaction training (SLIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophrenia Research 91, 112-116.
11. de Haan, L., Lavalaye, J., van Bruggen, M., van Nimwegen, L., Booij, J., van Amelsvoort, T., Linszen, D., 2004. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Canadian Journal of Psychiatry 49, 290-296. (Pubitemid 38724633)
12. Delay, J., Deneker, P., Harl, J.M., 1952. Utilisation en therapeutique psychiatrique d' une derivee d'hibernotherapie. Annales Médico- Psychologiques 110, 112-117.
13. Dolder, C.R., Lacro, J.P., Dunn, L.B., Jeste, D.V. 2002. Antipsychotic medication adherence: is there a difference between typical and atypical agents? American Journal of Psychiatry 159, 103-108. (Pubitemid 41070734)
14. Doroshow, D.B., 2007. Performing a cure for schizophrenia: insulin coma therapy on the wards. Journal of the History of Medicine and Allied Sciences 62, 213-243.
15. Feldman, R.P., Goodrich, J.T., 2001. Psychosurgery: a historical overview. Neurosurgery 48, 647-657.
16. Fountoulakis, K.N., Nimatoudis, I., Iacovides, A., Kaprinis, G., 2004. Off-label indications for atypical antipsychotics: a systematic review. Annals of General Hospital Psychiatry 3, 4.
17. Freeman, D., 2007. Suspicious minds: the psychology of persecutory delusions. Clinical Psychology Review 27, 425-457. (Pubitemid 46414047)
18. Garety, P.A., Hemsley, D.R., Wessely, S., 1991. Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. Journal of Nervous and Mental Disease 179, 194-201.
19. Guadagnoli, E., Velicer, W.F., 1988. Relation of sample-size to the stability of component patterns. Psychological Bulletin 103, 265-275.
20. Jones, S.R., Fernyhough, C., de-Wit, L., Meins, E., 2008. A message in the medium? Assessing the reliability of psychopathology e-questionnaires. Personality and Individual Differences 44, 349-359.
21. Kahn, R.S., Fleischhacker, W.W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I.P., Gheorghe, M.D., Rybakowski, J.K., Galderisi, S., Libiger, J., Hummer, M., Dollfus, S., Lopez-Ibor, J.J., Hranov, L.G., Gaebel, W., Peuskens, J., Lindefors, N., Riecher-Rossler, A., Grobbee, D.E., 2008. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371, 1085-1097. (Pubitemid 351418005)
22. Kapur, S., 2003. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 160, 13-23. (Pubitemid 36042420)
23. Kapur, S., Mizrahi, R., Li, M., 2005. From dopamine to salience to psychosis e linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research 79, 59-68. (Pubitemid 41362593)
24. Kapur, S., Remington, G., 2001. Dopamine D-2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biological Psychiatry 50, 873-883. (Pubitemid 34020700)
25. Keefe, R.S.E., Bilder, R.M., Davis, S.M., Harvey, P.D., Palmer, B.W., Gold, J.M., Meltzer, H.Y., Green, M.F., Capuano, G., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Roscnheck, R.A., Perkins, D.O., Davis, C.E., Hsiao, J.K., Lieberman, J.A., 2007. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64, 633-647. (Pubitemid 46878665)
26. Keefe, R.S.E., Seidman, L.J., Christensen, B.K., Hamer, R.M., Sharma, T., Sitskoorn, M.M., Lewine, R.R.J., Yurgelun-Todd, D.A., Gur, R.C., Tohen, M., Tollefson, G.D., Sanger, T.M., Lieberman, J.A., Grp, H.R., 2004. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in firstepisode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. American Journal of Psychiatry 161, 985-995. (Pubitemid 38735984)
27. Keefe, R.S.E., Silva, S.G., Perkins, D.O., Lieberman, J.A., 1999. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophrenia Bulletin 25, 201-222. (Pubitemid 29272501)
28. Klingberg, S., Schneider, S., Wittorf, A., Buchkremer, G., Wiedemann, G., 2008. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Psychiatry Research 161, 225-234.
29. Klingberg, S., Wittorf, A., Fischer, A., Jakob-Deters, K., Buchkremer, G., Wiedemann, G., 2010a. Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia. Acta Psychiatrica Scandinavica 121, 340-350.
30. Klingberg, S., Wittorf, A., Meisner, C., Wolwer, W., Wiedemann, G., Herrlich, J., Bechdolf, A., Muller, B.W., Sartory, G., Wagner, M., Kircher, T., Konig, H.H., Engel, C., Buchkremer, G., 2010b. Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial. Trials 11.
31. Konings, M., Bak, M., Hanssen, M., van Os, J., Krabbendam, L., 2006. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatrica Scandinavica 114, 55-61. (Pubitemid 43885486)
32. Laborit, H., Huguenard, P., 1951. L'hibernation artificielle par moyenes pharmacodynamiques et physiques. Presse Medicale 59, 13-29.
33. Lader, M., 1993. Neuroleptic-induced deficit syndrome e old problem, new challenge. Journal of Psychopharmacology 7, 392-393. (Pubitemid 23362787)
34. Lambert, M., Naber, D., 2009. Current Schizophrenia. Current Medicine Group, London.
35. Leucht, S., Arbter, D., Engel, R.R., Kissling, W., Davis, J.M., 2009. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry 14, 429-447.
36. Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, J., Hsiao, J.K., 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209-1223. (Pubitemid 41345943)
37. Lincoln, T.M., Suttner, C., Nestoriuc, Y., 2008. Effects of cognitive interventions for schizophrenia: a meta-analysis. Psychologische Rundschau 59, 217-232.
38. Lincoln, T.M., Wilhelm, K., Nestoriuc, Y., 2007. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Research 96, 232-245. (Pubitemid 47500142)
39. Lou, H.C., Skewes, J.C., Thomsen, K.R., Overgaard, M., Lau, H.C., Mouridsen, K., Roepstorff, A., 2011. Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words. Journal of Vision 11, pii:15.
40. Mishara, A.L., Goldberg, T.E., 2004. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biological Psychiatry 55, 1013-1022. (Pubitemid 38581917)
41. Mizrahi, R., Kiang, M., Mamo, D.C., Arenovich, T., Bagby, R.M., Zipursky, R.B., Kapur, S., 2006. The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophrenia Research 88, 111-118. (Pubitemid 44693243)
42. Moncrieff, J., Cohen, D., Mason, J.P., 2009. The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica 120, 102-111.
43. Moritz, S., Favrod, J., Andreou, C., Morrison, A.P., Bohn, F., Veckenstedt, R., Tonn, P., Karow, A., 2012. Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophrenia Bulletin. in press.
44. Moritz, S., Ferahli, S., Naber, D., 2004. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patientrated functioning with neuropsychological test results. Journal of the International Neuropsychological Society 10, 623-633. (Pubitemid 39077202)
45. Moritz, S., Jelinek, L., 2013. Inversion of the "unrealistic optimism" bias contributes to over-estimation of threat in obsessive-compulsive disorder. Behavioral and Cognitive Psychotherapy. in press.
46. Moritz, S., Laroi, F., 2008. Differences and similarities in the sensory and cognitive signatures of voice-hearing, intrusions and thoughts. Schizophrenia Research 102, 96-107.
47. Moritz, S., Peters, M.J.V., Karow, A., Deljkovic, A., Tonn, P., Naber, D., 2009. Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Medical Illness 1, 1-9.
48. Moritz, S., Van Quaquebeke, N., Lincoln, T.M., Köther, U., Andreou, C., 2013. Can we trust the Internet to measure psychotic symptoms? We should be cautious but not paranoid, submitted for publication.
49. Moritz, S., Veckenstedt, R., Randjbar, S., Vitzthum, F., Woodward, T.S., 2011. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychological Medicine 41, 1823-1832.
50. Moritz, S., Vitzthum, F., Randjbar, S., Veckenstedt, R., Woodward, T.S., 2010. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Current Opinion in Psychiatry 23, 561-569.
51. Moritz, S.,Woodward, T.S., Jelinek, L., Klinge, R., 2008. Memory and metamemory in schizophrenia: a liberal acceptance account of psychosis. Psychological Medicine 38, 825-832. (Pubitemid 351684599)
52. Moritz, S., Woodward, T.S., Ruff, C.C., 2003. Source monitoring and memory confidence in schizophrenia. Psychological Medicine 33, 131-139. (Pubitemid 36113408)
53. Morrison, A.P., Hutton, P.,Wardle, M., Spencer, H., Barratt, S., Brabban, A., Callcott, P., Christodoulides, T., Dudley, R., French, P., Lumley, V., Tai, S.J., Turkington, D., 2012. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial. Psychological Medicine 42,1049-1056.
54. Naber, D., Bandelow, B., Bender, S., Klimke, A., Kuhn, K., Lambert, M., Lemmer, W., Riedel, M., Vorbach, E., Dittmann, R.W., 2001. Subjective well-being under neuroleptic treatment with olanzapine versus clozapine: first results from a double-blind clinical trial using the SWN self-rating scale. Schizophrenia Research 49, 240-241.
55. Nasrallah, H.A., Lasser, R., 2006. Improving patient outcomes in schizophrenia: achieving remission. Journal of Psychopharmacology 20 (Suppl.), 57-61. (Pubitemid 44583377)
56. Nestoriuc, Y., Ladwig, I., Rief, W., 2011. Nebenwirkungen der Verhaltenstherapie e Vergleich zwischen einer Online-Studie und Patienten einer Hochschulambulanz (Side-effects of Behavior Therapy e A Comparison between Patients from an Online Study Versus those Treated at a University Outpatient Facility). DGPPN Congress, Berlin.
57. Pawlik, K., 1976. Dimensionen des Verhaltens. Eine Einführung in die Methodik und die Ergebnisse faktorenanalytischer psychologischer Forschung (Dimensions of Behavior: An Introduction into the Methodology and the Results of Factoranalytic Psychological Research). Huber, Bern.
58. Pharoah, F., Mari, J., Rathbone, J., Wong, W., 2010. Family intervention for schizophrenia. Cochrane Database of Systematic Reviews 12, CD000088.
59. Ritter, P., Lorig, K., Laurent, D., Matthews, K., 2004. Internet versus mailed questionnaires: a randomized comparison. Journal of Medical Internet Research 6, e29.
60. Riva, G., Teruzzi, T., Anolli, L., 2003. The use of the internet in psychological research: comparison of online and offline questionnaires. CyberPsychology & Behavior 6, 73-80. (Pubitemid 36278471)
61. Roberts, D.L., Penn, D.L., 2009. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Research 166, 141-147.
62. Sadock, B.J., Sadock, V.A., 2003. Kaplan and Sadock's Synopsis of Psychiatry, ninth ed. Lippincott Williams & Wilkins, Philadelphia, PA.
63. Saeedi, H., Remington, G., Christensen, B.K., 2006. Impact of haloperidol, a dopamine D-2 antagonist, on cognition and mood. Schizophrenia Research 85, 222-231. (Pubitemid 43947541)
64. San, L., Ciudad, A., Alvarez, E., Bobes, J., Gilaberte, I., 2007. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. European Psychiatry 22, 490-498. (Pubitemid 350087651)
65. Sarin, F.,Wallin, L., Widerlov, B., 2011. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials. Nordic Journal of Psychiatry 65, 162-174.
66. Schimmelmann, B.G., Paulus, S., Schacht, M., Tilgner, C., Schulte-Markwort, M., Lambert, M., 2005. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. Journal of Child and Adolescent Psychopharmacology 15, 249-258. (Pubitemid 40734104)
67. So, S.H., Freeman, D., Dunn, G., Kapur, S., Kuipers, E., Bebbington, P., Fowler, D., Garety, P.A., 2012. Jumping to conclusions, a lack of belief flexibility and delusional conviction in psychosis: a longitudinal investigation of the structure, frequency, and relatedness of reasoning biases. Journal of Abnormal Psychology 121, 129-139.
68. So, S.H., Garety, P.A., Peters, E.R., Kapur, S., 2010. Do antipsychotics improve reasoning biases? A review. Psychosomatic Medicine 72, 681-693.
69. Stahl, S.M., 1999. Psychopharmacology of Antipsychotics. Martin Duntz, London.
70. Taylor, D., Paton, C., Kapur, S., 2009. The Maudsley Prescribing Guidelines. Informa Healthcare, London.
71. van der Gaag, M., 2006. A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophrenia Bulletin 32, S113eS122.
72. Voruganti, L., Awad, A.G., 2004. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology 171, 121-132. (Pubitemid 38134648)
73. Voruganti, L., Slomka, P., Zabel, P., Costa, G., So, A., Mattar, A., Awad, A.G., 2001. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D-2 binding ratios on SPECT imaging. Neuropsychopharmacology 25, 642-650. (Pubitemid 32995946)
74. Voruganti, L.P., Baker, L.K., Awad, A.G., 2008. New generation antipsychotic drugs and compliance behaviour. Current Opinions in Psychiatry 21, 133-139. (Pubitemid 351339867)
75. Waller, H., Freeman, D., Jolley, S., Dunn, G., Garety, P., 2011. Targeting reasoning biases in delusions: a pilot study of the Maudsley Review Training Programme for individuals with persistent, high conviction delusions. Journal of Behavior Therapy and Experimental Psychiatry 42, 414-421.
76. Woodward, T.S., Buchy, L., Moritz, S., Liotti, M., 2007. A bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample. Schizophrenia Bulletin 33, 1023-1028. (Pubitemid 47216645)
77. Woodward, T.S., Moritz, S., Cuttler, C., Whitman, J.C., 2006. The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions in schizophrenia. Journal of Clinical and Experimental Neuropsychology 28, 605-617.
78. Woodward, T.S., Moritz, S., Menon, M., Klinge, R., 2008. Belief inflexibility in schizophrenia. Cognitive Neuropsychiatry 13, 267-277. (Pubitemid 351891614)
79. Wykes, T., Steel, C., Everitt, B., Tarrier, N., 2008. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 34, 523-537.